Back to Search Start Over

Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer

Authors :
Yann Kieffer
Claire Bonneau
Inna Kuperstein
Anne Vincent-Salomon
Laetitia Fuhrmann
Ana Catarina Costa
Fatima Mechta-Grigoriou
Anne-Marie Givel
Vassili Soumelis
Ilaria Magagna
Maria Carla Parrini
Andrei Zinovyev
Alix Scholer-Dahirel
Melissa Cardon
Philémon Sirven
Brigitte Bourachot
Maria Kondratova
Charles Bernard
Floriane Pelon
Mechta-Grigoriou, Fatima
Equipements d'excellence - Equipement de biologie intégrative du cancer pour une médecine personnalisée - - ICGex2010 - ANR-10-EQPX-0003 - EQPX - VALID
Unité de génétique et biologie des cancers (U830)
Université Paris Descartes - Paris 5 (UPD5)-Institut Curie [Paris]-Institut National de la Santé et de la Recherche Médicale (INSERM)
Immunité et cancer (U932)
Institut Curie [Paris]
Cancer et génome: Bioinformatique, biostatistiques et épidémiologie d'un système complexe
Mines Paris - PSL (École nationale supérieure des mines de Paris)
Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Institut Curie [Paris]-Institut National de la Santé et de la Recherche Médicale (INSERM)
Service de Pathologie [Institut Curie]
A.C. was supported by funding from the Fondation de France (2012-00034102) and the Fondation Pierre-Gilles de Gennes (FPGG0048). Y.K. was supported by the Institut National Du Cancer (INCa-DGOS-9963) and the Fondation pour la Recherche Médicale (FRM ING20130526797). M.C. was supported by the SiRIC-Curie program (INCa-DGOS-4654). The experimental work was supported by grants from the Institut National de la Santé et de la Recherche Médicale (Inserm), the Institut Curie, in particular the PIC TME and the PIC3i CAFi, the Ligue Nationale Contre le Cancer (Labelisation), the ICGex (ANR-10-EQPX-03), and INCa (INCa-DGOS-9963). We are very grateful to our funders for providing support these last years.
ANR-10-EQPX-0003,ICGex,Equipement de biologie intégrative du cancer pour une médecine personnalisée(2010)
MINES ParisTech - École nationale supérieure des mines de Paris
Source :
Cancer Cell, Cancer Cell, 2018, 33 (3), pp.463-479.e10. ⟨10.1016/j.ccell.2018.01.011⟩, Cancer Cell, Elsevier, 2018, 33 (3), pp.463-479.e10. ⟨10.1016/j.ccell.2018.01.011⟩
Publication Year :
2017

Abstract

Comment inBreast cancer: Fibroblast subtypes alter the microenvironment. [Nat Rev Clin Oncol. 2018]; International audience; Carcinoma-associated fibroblasts (CAF) are key players in the tumor microenvironment. Here, we characterize four CAF subsets in breast cancer with distinct properties and levels of activation. Two myofibroblastic subsets (CAF-S1, CAF-S4) accumulate differentially in triple-negative breast cancers (TNBC). CAF-S1 fibroblasts promote an immunosuppressive environment through a multi-step mechanism. By secreting CXCL12, CAF-S1 attracts CD4+CD25+ T lymphocytes and retains them by OX40L, PD-L2, and JAM2. Moreover, CAF-S1 increases T lymphocyte survival and promotes their differentiation into CD25HighFOXP3High, through B7H3, CD73, and DPP4. Finally, in contrast to CAF-S4, CAF-S1 enhances the regulatory T cell capacity to inhibit T effector proliferation. These data are consistent with FOXP3+ T lymphocyte accumulation in CAF-S1-enriched TNBC and show how a CAF subset contributes to immunosuppression.

Details

ISSN :
18783686 and 15356108
Volume :
33
Issue :
3
Database :
OpenAIRE
Journal :
Cancer cell
Accession number :
edsair.doi.dedup.....4b8d21dd877774adcbf38291c18dd280
Full Text :
https://doi.org/10.1016/j.ccell.2018.01.011⟩